No Data
Bowling Bao: First quarter report 2025
Bowling Bao: 2024 Annual Report
Bowling Bao: 2024 Annual Report Summary
Baolingbao Biology (002286.SZ): Net income of 0.111 billion yuan in 2024, an increase of 105.97% year-on-year.
Gelonghui reported on April 24 that Baolingbao Biology (002286.SZ) announced its 2024 annual report, achieving revenue of 2.402 billion yuan, a year-on-year decrease of 4.84%; net income attributable to shareholders of the listed company was 0.111 billion yuan, an increase of 105.97% year-on-year; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.124 billion yuan, an increase of 254.56% year-on-year; EPS was 0.30 yuan. It is proposed to distribute a cash dividend of 0.6 yuan (tax included) for every 10 shares to all shareholders.
Baolingbao Biology Dismisses Deputy General Manager
Baolingbao Biology (002286.SZ): Dismissed Deputy General Manager Zhang Guogang from his position.
On April 20, Gelonghui reported that Baolingbao Biology (002286.SZ) announced, in accordance with relevant regulations and upon the nomination of the general manager, that the Board of Directors agreed to dismiss Deputy General Manager Zhang Guogang from his position, and he will not hold any position in the company after the dismissal, effective from the date of approval by the Board of Directors.
Pinning Down Baolingbao Biology Co.,Ltd.'s (SZSE:002286) P/E Is Difficult Right Now
